fludioxonil has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, YS; Choi, KC; Go, RE; Jeon, SY; Jeung, EB; Kim, CW; Nam, KH | 1 |
| Choi, KC; Hwang, KA; Lee, GH | 1 |
2 other study(ies) available for fludioxonil and cyclin d1
| Article | Year |
|---|---|
Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Breast Neoplasms; Cadherins; Cathepsin D; Cell Movement; Cell Proliferation; Cell Shape; Cyclin D1; Dioxoles; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Pyrroles; Receptors, Estrogen; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Effects of Fludioxonil on the Cell Growth and Apoptosis in T and B Lymphocytes.
Topics: B-Lymphocytes; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin E; Dioxoles; Fungicides, Industrial; Gene Expression Regulation; Humans; Jurkat Cells; Membrane Potential, Mitochondrial; Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrroles; T-Lymphocytes; Time Factors; Tumor Suppressor Protein p53 | 2019 |